Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 8,12-epoxy-1h,8h-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-
1. Staurosporin
2. 62996-74-1
3. (+)-staurosporine
4. Antibiotic 230
5. Am-2282
6. Antibiotic Am 2282
7. Ccris 3272
8. Antibiotic Am-2282
9. Alkaloid Am-2282 From Streptomyces
10. H88epa0a3n
11. Chembl388978
12. Chebi:15738
13. C28h26n4o3
14. 8,12-epoxy-1h,8h-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-
15. (5s,6r,7r,9r)-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5h,14h-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-14-one
16. (5s,6r,7r,9r)-6-methoxy-5-methyl-7-methylamino-6,7,8,9,15,16-hexahydro-5h,14h-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one
17. Unii-h88epa0a3n
18. Gnf-pf-1389
19. Methoxy-methyl-(methylamino)[?]one
20. Sr-00000001485
21. Cgp-39360
22. Dtxsid6041131
23. Staurosporin, 4
24. 1nvr
25. 1stc
26. 1xbc
27. 1xjd
28. 1yhs
29. 2gcd
30. Staurosporine, 8
31. Cgp 39360
32. Staurosporine & Tnf
33. 1q3d
34. 1sm2
35. 2dq7
36. Staurosporine [mi]
37. Molmap_000047
38. Schembl8157
39. Cbiol_001978
40. Bspbio_001146
41. Gtpl346
42. Bdbm2579
43. Megxm0_000307
44. 1u59
45. Bcpp000063
46. Bio1_000264
47. Bio1_000753
48. Bio1_001242
49. Hms1990j07
50. Hms3650b17
51. Ex-a1777
52. Zinc3814434
53. Am2282
54. Mfcd18252446
55. Nsc755774
56. S1421
57. Staurosporin And Antibiotic Am-2282
58. Akos015897119
59. Am 2282
60. Ccg-208052
61. Db02010
62. Nsc-755774
63. Qtl1_000078
64. Ncgc00162400-01
65. Ncgc00162400-02
66. Ncgc00162400-03
67. Ncgc00162400-04
68. Ncgc00162400-05
69. Ncgc00162400-06
70. Ncgc00162400-09
71. 9,13-epoxy-1h,9h-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)-benzodiazonin-1-one, 2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-, (9s-(9alpha,10beta,11beta,13alpha)-
72. Ac-35765
73. Hy-15141
74. Staurosporine & Tumor Necrosis Factor (tnf)
75. Staurosporine 100 Microg/ml In Acetonitrile
76. T4000
77. Q5957181
78. Sr-00000001485-4
79. Brd-k17953061-001-02-8
80. Brd-k17953061-001-04-4
81. Brd-k17953061-001-05-1
82. Brd-k17953061-001-08-5
83. Brd-k17953061-001-10-1
84. Brd-k17953061-001-11-9
85. (2s,3r,4r,6r)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8(13),9,11,14(28),15(19),20(27),21(26),22,24-nonaen-16-one
86. (2s,3r,4r,6r)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8,10,12,14(28),15(19),20(27),21,23,25-nonaen-16-one
87. (2s,3r,4r,6r)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one
88. (5s,6r,7r,9r)-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5h,14h-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one
89. (9s,10r,11r,13r)- 2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1h,9h-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-1-one
90. [9s-(9?,10?,11?,13?)]-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1h,9h-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one
91. 109189-95-9
92. 9,13-epoxy-1h,9h-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one, 2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-, (9s,10r,11r,13r)- & Tumor Necrosis Factor (tnf)
93. 9,13-epoxy-1h,9h-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one, 2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-, (9s,10r,11r,13r)- (9ci)
94. 9,13-epoxy-1h,9h-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one, 2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-, [9s-(9alpha,10beta,11beta,13alpha)]-
Molecular Weight | 466.5 g/mol |
---|---|
Molecular Formula | C28H26N4O3 |
XLogP3 | 3.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 466.20049070 g/mol |
Monoisotopic Mass | 466.20049070 g/mol |
Topological Polar Surface Area | 69.4 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 901 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
A Staurosporine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Staurosporine, including repackagers and relabelers. The FDA regulates Staurosporine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Staurosporine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Staurosporine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Staurosporine supplier is an individual or a company that provides Staurosporine active pharmaceutical ingredient (API) or Staurosporine finished formulations upon request. The Staurosporine suppliers may include Staurosporine API manufacturers, exporters, distributors and traders.
click here to find a list of Staurosporine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Staurosporine DMF (Drug Master File) is a document detailing the whole manufacturing process of Staurosporine active pharmaceutical ingredient (API) in detail. Different forms of Staurosporine DMFs exist exist since differing nations have different regulations, such as Staurosporine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Staurosporine DMF submitted to regulatory agencies in the US is known as a USDMF. Staurosporine USDMF includes data on Staurosporine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Staurosporine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Staurosporine suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Staurosporine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Staurosporine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Staurosporine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Staurosporine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Staurosporine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Staurosporine suppliers with NDC on PharmaCompass.
Staurosporine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Staurosporine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Staurosporine GMP manufacturer or Staurosporine GMP API supplier for your needs.
A Staurosporine CoA (Certificate of Analysis) is a formal document that attests to Staurosporine's compliance with Staurosporine specifications and serves as a tool for batch-level quality control.
Staurosporine CoA mostly includes findings from lab analyses of a specific batch. For each Staurosporine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Staurosporine may be tested according to a variety of international standards, such as European Pharmacopoeia (Staurosporine EP), Staurosporine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Staurosporine USP).
LOOKING FOR A SUPPLIER?